Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates. - Wikidata - awgldk - TriplyDB

Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates.

Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates.

http://www.wikidata.org/entity/Q34217441

about

The quality of Medicaid and Medicare data obtained from CMS and its contractors: implications for pharmacoepidemiology.Application of a framework for determining number of drugs.Improving medical record retrieval for validation studies in Medicare data.Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right?

P2860

Q33608853-E7B0CEA1-2CAF-4224-837D-3AE44D780ACF Q36017719-F916B383-7EBD-4CCF-B722-D1D07C4D670A Q36333473-B689AAA2-4D7E-4404-966A-0A8D87B86F4C Q55433025-13040232-1CDA-44DB-A7CC-1DD268889845

P2860

Field methods in medical record abstraction: assessing the properties of comparative effectiveness estimates.

http://www.wikidata.org/entity/Q34217441

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Field methods in medical recor ...... ative effectiveness estimates.

@ast

Field methods in medical recor ...... ative effectiveness estimates.

@en

Field methods in medical recor ...... ative effectiveness estimates.

@nl

type

label

Field methods in medical recor ...... ative effectiveness estimates.

@ast

Field methods in medical recor ...... ative effectiveness estimates.

@en

Field methods in medical recor ...... ative effectiveness estimates.

@nl

prefLabel

Field methods in medical recor ...... ative effectiveness estimates.

@ast

Field methods in medical recor ...... ative effectiveness estimates.

@en

Field methods in medical recor ...... ative effectiveness estimates.

@nl

P1433

Q34217441-CF5ACBCD-1927-43B3-BA10-2470D85B92AC

P1476

Q34217441-4BEB4FC5-1A2D-4410-9F7B-44C6FA4486FE

P2093

Q34217441-035F10D1-02EF-44F8-A4E4-BEB56D89050C

Q34217441-226BC1EA-C773-4A9E-A0AF-319EA13F751B

Q34217441-25D595EE-6A49-4B5D-B17D-125EC746D7CD

Q34217441-7F1BE19B-B6FA-46FE-A8EC-79F1600E24A0

Q34217441-956E4E3E-D73F-4CDC-A335-3646B63D6BD4

Q34217441-95C3E749-88E2-4B78-A206-597EEB37F021

P2860

Q34217441-0309D2EF-AC8D-452B-9904-72F6E3F7CA4F

Q34217441-04DB7D78-031B-4165-B1CF-804375A7E5F3

Q34217441-42F7D1C1-9D28-4A6C-827B-8B846157981F

Q34217441-4EB95239-E61C-49AC-A00A-2275E81798CF

Q34217441-56AE02BA-9596-4DB1-9C31-C0149CE8468C

Q34217441-78D9EB58-22CA-4EA1-99B8-9E03F876F5FB

Q34217441-7A0BA02C-3318-490D-A38C-B45BAC909419

Q34217441-AB67C81A-21D7-4E66-A059-A64472D046C9

Q34217441-BB915280-B0EE-4B40-BDB4-1E5ABA098186

Q34217441-F5E946D1-6440-4B06-8B2E-BCD5CB894054

P2888

Q34217441-A4848F80-FCDB-4628-B8CC-F1D65529AF75

P304

Q34217441-FFBD3D4C-DD1A-4227-BDD0-6D0328D15CD3

P31

Q34217441-F48D3EFF-6840-4ECB-95B0-682C7F739049

P356

Q34217441-344F9546-96F4-4870-A42F-4AC3BB4A5E3A

P478

Q34217441-19DBE94E-0294-430D-B7C0-0032CF7D149A

P50

Q34217441-3B45CFAF-9B41-4F1F-9440-526CDDB0352E

P577

Q34217441-3C231BCE-0819-485D-967C-98A8FD783BBA

P5875

Q34217441-6AFE2A38-B5A6-4A9E-997A-1A21E8C5197E

P6179

Q34217441-539024C9-7CD3-4905-B905-779821BBD108

P698

Q34217441-70DC674B-869E-40BD-985D-B40BB4988F6E

P932

Q34217441-D679E629-A871-4E54-AA6F-35B87CEF62D6

P356

1472-6963-14-391

P1433

BMC Health Services Research

P1476

Field methods in medical recor ...... ative effectiveness estimates.

@en

P2093

Elizabeth A Cook

http://www.w3.org/2001/XMLSchema#string

Jane Pendergast

http://www.w3.org/2001/XMLSchema#string

Jennifer Robinson

http://www.w3.org/2001/XMLSchema#string

John Brooks

http://www.w3.org/2001/XMLSchema#string

June Wilwert

http://www.w3.org/2001/XMLSchema#string

Kathleen M Schneider

http://www.w3.org/2001/XMLSchema#string

P2860

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data.

The art and science of chart review.

Accounting for unobservable exposure time bias when using Medicare prescription drug data.

Adjustments for unmeasured confounders in pharmacoepidemiologic database studies using external information.

A comparison of administrative versus clinical data: coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team.

What is the effect of area size when using local area practice style as an instrument?

Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project.

Design of the Women’s Health Initiative Clinical Trial and Observational Study

P2888

1472-6963-14-391

P304

391

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1472-6963-14-391

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

Elizabeth A Chrischilles

P577

2014-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265691188

http://www.w3.org/2001/XMLSchema#string

P6179

1038259367

http://www.w3.org/2001/XMLSchema#string

P698

25223597

http://www.w3.org/2001/XMLSchema#string

P932

4169833

http://www.w3.org/2001/XMLSchema#string